{
  "document_number": "E9-5441",
  "executive_order_number": "13505",
  "title": "Removing Barriers to Responsible Scientific Research Involving Human Stem Cells",
  "abstract": null,
  "signing_date": "2009-03-09",
  "publication_date": "2009-03-11",
  "president": {
    "identifier": "barack-obama",
    "name": "Barack Obama"
  },
  "html_url": "https://www.federalregister.gov/documents/2009/03/11/E9-5441/removing-barriers-to-responsible-scientific-research-involving-human-stem-cells",
  "pdf_url": "https://www.govinfo.gov/content/pkg/FR-2009-03-11/pdf/E9-5441.pdf",
  "raw_text_url": "https://www.federalregister.gov/documents/full_text/text/2009/03/11/E9-5441.txt",
  "enrichment": {
    "summary": "This executive order removes previous restrictions on federal funding for research involving human embryonic and non-embryonic stem cells. It directs the Department of Health and Human Services and the NIH to support and conduct responsible stem cell research, update guidance accordingly, and revokes earlier presidential policies limiting such research.",
    "theme_ids": [
      "stem-cell-biomedical-research",
      "bioethics",
      "revocation-of-previous-executive-orders"
    ],
    "impacted_populations": {
      "positive_ids": [
        "scientific-researchers",
        "patients-general",
        "individuals-with-chronic-illnesses"
      ],
      "negative_ids": [
        "faith-based-communities"
      ]
    },
    "potential_concerns": [
      "The removal of funding restrictions may raise bioethical concerns among faith-based communities opposing embryonic stem cell research.",
      "Expanded federal support for stem cell research could lead to contentious debates impacting patients with chronic illnesses awaiting new therapies, potentially delaying broader consensus and implementation.",
      "Scientific researchers might face challenges ensuring responsible oversight and ethical safeguards in line with updated NIH guidance amid rapidly advancing stem cell technologies.",
      "There is a risk that the revocation of previous executive limits may provoke political or legal challenges, disrupting research progress and affecting patients relying on experimental treatments."
    ],
    "enriched_at": "2025-12-15T01:59:08.468Z",
    "model_used": "gpt-4.1-mini"
  }
}